The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Excessive acute migraine medication use and migraine progression
Abstract
Long considered a chronic disorder with a stable course, recent research demonstrates that, in a subgroup, migraine progresses to chronic migraine. Among the risk factors for migraine progression, acute symptomatic medication overuse (SMO) is regarded as one of the most important. Though SMO and chronic migraine are associated, several questions remain unanswered. First, the causal path is controversial (SMO as a cause or consequence). Second, it is unclear if specific classes of medication, as well as critical doses of exposures, are necessary. Herein we review this topic in the light of recent conducted research. Although several caveats exist and the data should be taken with caution, important findings are as follows: 1) Opiates are associated with migraine progression; critical dose of exposure is around 8 days per month, and the effect is more pronounced in men. 2) Barbiturates are also associated with migraine progression. Critical dose of exposure is around 5 days per month and the effect is more pronounced in women. 3) Triptans induced migraine progression in those with high frequency of migraine at baseline (10–14 days per month), but not overall. 4) Anti-inflammatory medications were protective in those with <10 days of headache at baseline, and, as triptans, induced migraine progression in those with high frequency of headaches. Accordingly, specific classes of medications are associated with migraine progression, and high frequency of headaches seems to be a risk factor for chronic migraine regardless of medication exposure. GLOSSARY: AMPP = American Migraine Prevalence and Prevention study; CDH = chronic daily headache; CM = chronic migraine; EM = episodic migraine; ICHD = International Classification of Headache Disorders; NDPH = new daily persistent headache; NSAID = nonsteroidal anti-inflammatory drugs; OTC = over the counter; RR = risk ratio; SMO = symptomatic medication overuse; TM = transformed migraine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorge, F., Simone, R. D., Marano, E., Nolano, M., Orefice, G., & Carrieri, P. (1988) · Cephalalgia · doi:10.1046/j.1468-2982.1988.0801001.x · Cited by 3,465
The global burden of headache: A documentation of headache prevalence and disability worldwide
Stovner, L., Hagen, K., Jensen, R., Katsarava, Z., Lipton, R., Scher, A., Steiner, T., & Zwart, J.-A. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01288.x · Cited by 2,444
Self-citationMigraine prevalence, disease burden, and the need for preventive therapy
Lipton, R. B., Bigal, M. E., Diamond, M., Freitag, F., Reed, M. L., & Stewart, W. F. (2007) · Neurology · doi:10.1212/01.wnl.0000252808.97649.21 · Cited by 2,337
Self-citationOlesen, J. (2004) · Cephalalgia · doi:10.1111/j.1468-2982.2003.00824.x · Cited by 2,056
New Appendix Criteria Open for a Broader Concept of Chronic Migraine
Olesen, J., Bousser, M.-G., Diener, H.-C., Dodick, D., First, M., Goadsby, P., Göbel, H., Lainez, M., Lance, J., Lipton, R., et al. (2006) · Cephalalgia · doi:10.1111/j.1468-2982.2006.01172.x · Cited by 909
Self-citationBigal, M. E., Serrano, D., Buse, D., Scher, A., Stewart, W. F., & Lipton, R. B. (2008) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2008.01217.x · Cited by 845
Self-citationMajor increases in opioid analgesic abuse in the United States: Concerns and strategies
Compton, W. M., & Volkow, N. D. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.05.009 · Cited by 830
Scher, I. A., Stewart, F. W., Ricci, A. J., & Lipton, B. R. (2003) · Pain · doi:10.1016/s0304-3959(03)00293-8 · Cited by 716
Epidemiology of Chronic Daily Headache in the General Population
Castillo, J., Muñoz, P., Guitera, V., & Pascual, J. (1999) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1999.3903190.x · Cited by 714
Classification of daily and near-daily headaches: Field trial of revised IHS criteria
Silberstein, S. D., Lipton, R. B., & Sliwinski, M. (1996) · Neurology · doi:10.1212/wnl.47.4.871 · Cited by 611
Self-citation
Research works printed but not linked: 1
- 10.1046/j.1468-2982.1994.1406443.x · doi:10.1046/j.1468-2982.1994.1406443.x
Cited by
Migraine and cardiovascular disease: A population-based study
Bigal, M. E., Kurth, T., Santanello, N., Buse, D., Golden, W., Robbins, M., & Lipton, R. B. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d0cc8b · Cited by 367
Self-citationCharacterization of a novel model of chronic migraine
Pradhan, A. A., Smith, M. L., McGuire, B., Tarash, I., Evans, C. J., & Charles, A. (2014) · Pain · doi:10.1016/j.pain.2013.10.004 · Cited by 339
Adams, A. M., Serrano, D., Buse, D. C., Reed, M. L., Marske, V., Fanning, K. M., & Lipton, R. B. (2015) · Cephalalgia · doi:10.1177/0333102414552532 · Cited by 305
Self-citationMigraine: integrated approaches to clinical management and emerging treatments
Ashina, M., Buse, D. C., Ashina, H., Pozo-Rosich, P., Peres, M. F. P., Lee, M. J., Terwindt, G. M., Halker Singh, R., Tassorelli, C., Do, T. P., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32342-4 · Cited by 305
When pain gets stuck: the evolution of pain chronification and treatment resistance
Borsook, D., Youssef, A. M., Simons, L., Elman, I., & Eccleston, C. (2018) · Pain · doi:10.1097/j.pain.0000000000001401 · Cited by 281
Metadata
- Authors
- Bigal, M. E., & Lipton, R. B.
- Venue
- Neurology
- Published
- 2008-11-25
- Volume
- 71
- Issue
- 22
- Pages
- 1821-1828
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2023102259
- Cited by
- 292
- References
- 35
- FWCI
- 12.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Excessive acute migraine medication use and migraine progression. https://app.cochat.ai/papers/10.1212/01.wnl.0000335946.53860.1d
- The paper
- Bigal, M. E., & Lipton, R. B. (2008). Excessive acute migraine medication use and migraine progression. Neurology. https://doi.org/10.1212/01.wnl.0000335946.53860.1d
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.